Colucid Pharmaceuticals Logo Image

Colucid Pharmaceuticals

Colucid Pharmaceuticals has reached its limit for report views.

Please check back to see if Colucid Pharmaceuticals has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report, Interactive Annual Report and Form 10K

Colucid Pharmaceuticals

Colucid Pharmaceuticals does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



About Colucid Pharmaceuticals

1-10 Employees
Based in Cambridge, Massachusetts

CoLucid was founded in 2005 and is developing oral lasmiditan for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of unspecified headache pain in adults in emergency room and other urgent care settings.

Ticker:
CLCD
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol